Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2021 Results - Earnings Call Transcript

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET

Company Participants

Timothy McCarthy - LifeSci Advisors
Sergio Traversa - CEO & Director
Charles Ence - Chief Accounting & Compliance Officer
Charles Gorodetzky - Former Scientific Director, National Institute of Drug Abuse Addiction Research Center

Conference Call Participants

Marc Goodman - SVB Leerink
Andrea Tan - Goldman Sachs Group
Joon Lee - Truist Securities
Jay Olson - Oppenheimer
Eddie Hickman - Guggenheim Securities
Andrew Tsai - Jefferies

Operator

Thank you for standing by. This is the conference operator. Welcome to the Relmada Therapeutics Second Quarter 2021 Earnings Call. [Operator Instructions].

I would now like to turn the conference over to Mr. Tim McCarthy from LifeSci Advisors. Please go ahead.

Timothy McCarthy

Thank you, Rachel, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa; and Chief Accounting and Compliance Officer, Chuck Ence. This afternoon, Relmada issued a news release providing a business update and announcing financial results for the 3 and 6 months ended June 30, 2021, and filed its quarterly report on Form 10-Q with the SEC.

Please note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Relmada's management team will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified by the cautionary statements contained in Relmada's press release issued today and the company's SEC filings, including in the annual report on Form 10-K for the year ended December 30, 2020, and subsequent filings.

This conference call also contains